Home / Benchmarks / Laboratory Services
Laboratory ServicesM&A Activity
Deal flow, active acquirers, and current market trend - based on 317real disclosed M&A transactions in the laboratory services space. Run the calculator below to price your business at current multiples.
State of Laboratory ServicesM&A in 2026
The laboratory services M&A market is tracked across 317 disclosed transactions in the ExitValue.ai database (139 with EBITDA disclosed, 306 with revenue). The current market trend is consolidating.
Active acquirers include Zoetis, Swiss Rockets AG, Abbott, Eurofins Scientific. Recent named transactions: GeneSeek (Neogen Animal Genomics) (2026); Complete Genomics, Inc. (2026); Exact Sciences (2025).
Premium valuations in laboratory services are driven by specialty test menu (toxicology, molecular, infectious disease) above 40% of volume; bidirectional lis / emr integration (epic / cerner / athena clients = sticky revenue); diversified payer contract base with in-network breadth across 5+ commercial plans.
What compresses valuations: covid pcr over-indexing in the 2020-2022 base (revenue cliff priced in by buyers); single-payer concentration above 50% (labcorp / quest commercial-rate pressure); clia / cap citation history or kickback compliance exposure (deal-killer for institutional buyer).
Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.
Recent named M&A deals in laboratory services
Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).
Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.
Get an instant valuation for your laboratory services
Backed by the same 317 disclosed transactions, adjusted for your specific size and margin.
Get your full valuation analysis
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
What drives a premium valuation
- ●Specialty test menu (toxicology, molecular, infectious disease) above 40% of volume
- ●Bidirectional LIS / EMR integration (Epic / Cerner / Athena clients = sticky revenue)
- ●Diversified payer contract base with in-network breadth across 5+ commercial plans
What compresses valuation
- ●COVID PCR over-indexing in the 2020-2022 base (revenue cliff priced in by buyers)
- ●Single-payer concentration above 50% (LabCorp / Quest commercial-rate pressure)
- ●CLIA / CAP citation history or kickback compliance exposure (deal-killer for institutional buyer)
Laboratory Services valuation: common questions
How is a laboratory services business valued?
Laboratory Services businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.
What drives laboratory services valuation?
The biggest value levers in laboratory services are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for specialty test menu (toxicology, molecular, infectious disease) above 40% of volume; bidirectional lis / emr integration (epic / cerner / athena clients = sticky revenue); diversified payer contract base with in-network breadth across 5+ commercial plans.
How many laboratory services M&A deals are tracked?
ExitValue.ai tracks 317 disclosed laboratory services M&A transactions, 139 with EBITDA disclosed, 306 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: consolidating.
Who buys laboratory services businesses?
Laboratory Services businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Zoetis, Swiss Rockets AG, Abbott, Eurofins Scientific.
What is my laboratory services business worth?
Run the ExitValue.ai laboratory services calculator to see your business priced against the 317 disclosed laboratory services transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.
More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Who buys laboratory services businesses?· active buyers
- Recent deal: GeneSeek (Neogen Animal Genomics)· comparable transaction
- Who acquired GeneSeek (Neogen Animal Genomics)?· buyer profile
- How to value a laboratory services· long-form guide
Methodology details: how ExitValue computes valuation ranges · full laboratory services calculator